title: 13-cis retinoic acid and interferon-alpha +/- irradiation in the treatment of squamous-cell carcinomas.
authors.affiliation: Department of Radiotherapy, University of Tübingen, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Hoffmann
authors.forename: M
authors.initials: M
authors.lastname: Schiebe
authors.forename: P
authors.initials: P
authors.lastname: Hirnle
authors.forename: R
authors.initials: R
authors.lastname: Souchon
authors.forename: M
authors.initials: M
authors.lastname: Clemens
authors.forename: I
authors.initials: I
authors.lastname: Adamietz
authors.forename: M
authors.initials: M
authors.lastname: Bamberg
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D005240:Feasibility Studies; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D015474:Isotretinoin / Q000009:adverse effects / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000532:radiotherapy
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha; D015474:Isotretinoin